A new category of drug candidates for treating high cholesterol by inhibiting the PCSK9 protein. First approval (by EU) mid 2015.
The following 6 pages are in this category, out of 6 total. This list may not reflect recent changes.
A new category of drug candidates for treating high cholesterol by inhibiting the PCSK9 protein. First approval (by EU) mid 2015.
The following 6 pages are in this category, out of 6 total. This list may not reflect recent changes.